Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:686-691
Published online before print December 29, 2004, doi: 10.1161/01.ATV.0000154774.71187.f0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/4/686    most recent
01.ATV.0000154774.71187.f0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, K.
Right arrow Articles by Terkeltaub, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, K.
Right arrow Articles by Terkeltaub, R.
Related Collections
Right arrow Animal models of human disease
Right arrow Cell biology/structural biology
Right arrow Other Vascular biology
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:686.)
© 2005 American Heart Association, Inc.


Vascular Biology

Chondrogenesis Mediated by PPi Depletion Promotes Spontaneous Aortic Calcification in NPP1–/– Mice

Kristen Johnson; Monika Polewski; Deborah van Etten; Robert Terkeltaub

From Rheumatology/Medicine, Veterans Affairs Medical Center/University of California at San Diego, School of Medicine.

Correspondence to Robert Terkeltaub, 111K, Veterans Affairs Medical Center, 3350 La Jolla Village Dr, San Diego, CA 92161. E-mail rterkeltaub{at}ucsd.edu

Objective— We recently linked human arterial media calcification of infancy to heritable PC-1/nucleotide pyrophosphatase phosphodiesterase 1 (NPP1) deficiency. NPP1 hydrolyzes ATP to generate PPi, a physicochemical inhibitor of hydroxyapatite crystal growth. But pathologic calcification in NPP1 deficiency states is tissue-restricted and in perispinal ligaments is endochondral differentiation–mediated rather than simply a dystrophic process. Because ectopic chondro-osseous differentiation promotes artery calcification in atherosclerosis and other disorders, we tested the hypothesis that NPP1 and PPi deficiencies regulate cell phenotype plasticity to promote artery calcification.

Methods and Results— Using cultured multipotential NPP1–/– mouse bone marrow stromal cells, we demonstrated spontaneous chondrogenesis inhibitable by treatment with exogenous PPi. We also demonstrated cartilage-specific gene expression, upregulated alkaline phosphatase, decreased expression of the physiological calcification inhibitor osteopontin, and increased calcification in NPP1–/– aortic smooth muscle cells (SMCs). Similar changes were demonstrated in aortic SMCs from ank/ank mice, which are extracellular PPi–depleted because of defective ANK transmembrane PPi transport activity. Moreover, NPP1–/– and ank/ank mice demonstrated aortic media calcification by von Kossa staining, and intra-aortic cartilage-specific collagen gene expression was demonstrated in situ in NPP1–/– mice.

Conclusions— NPP1 and PPi deficiencies modulate phenotype plasticity in artery SMCs and chondrogenesis in mesenchymal precursors, thereby stimulating artery calcification by modulating cell differentiation.

Human "idiopathic" infantile arterial media calcification is linked to deficient PPi-generating PC-1/nucleotide pyrophosphatase phosphodiesterase 1 (NPP1). We demonstrate that NPP1 and extracellular PPi deficiencies promote chondrogenic differentiation in mesenchymal precursors and vascular smooth muscle cells. Therefore, NPP1 and PPi deficiencies promote active rather than simply dystrophic artery calcification, mediated partly by primary alterations in cell differentiation.


Key Words: nucleotide pyrophosphatase phosphodiesterase 1 • osteopontin • vascular smooth muscle cells • ank/ank


Related Article:

Inorganic Pyrophosphate: A Paracrine Regulator of Vascular Calcification and Smooth Muscle Phenotype
Dwight A. Towler
Arterioscler. Thromb. Vasc. Biol. 2005 25: 651-654. [Full Text] [PDF]



This article has been cited by other articles:


Home page
CirculationHome page
L. L. Demer and Y. Tintut
Vascular Calcification: Pathobiology of a Multifaceted Disease
Circulation, June 3, 2008; 117(22): 2938 - 2948.
[Full Text] [PDF]


Home page
Circ. Res.Home page
K. A. Johnson, M. Polewski, and R. A. Terkeltaub
Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle Cells
Circ. Res., March 14, 2008; 102(5): 529 - 537.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
D. A. Towler
Vascular Calcification: A Perspective On An Imminent Disease Epidemic
IBMS BoneKEy, February 1, 2008; 5(2): 41 - 58.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. A. Johnson, W. Yao, N. E. Lane, P. Naquet, and R. A. Terkeltaub
Vanin-1 Pantetheinase Drives Increased Chondrogenic Potential of Mesenchymal Precursors in ank/ank Mice
Am. J. Pathol., February 1, 2008; 172(2): 440 - 453.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Eller, K. Hochegger, G. M. Feuchtner, E. Zitt, I. Tancevski, A. Ritsch, F. Kronenberg, A. R. Rosenkranz, J. R. Patsch, and G. Mayer
Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 321 - 327.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Al-Aly, J.-S. Shao, C.-F. Lai, E. Huang, J. Cai, A. Behrmann, S.-L. Cheng, and D. A. Towler
Aortic Msx2-Wnt Calcification Cascade Is Regulated by TNF-{alpha} Dependent Signals in Diabetic Ldlr / Mice
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2589 - 2596.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. L. Schiffrin, M. L. Lipman, and J. F.E. Mann
Chronic Kidney Disease: Effects on the Cardiovascular System
Circulation, July 3, 2007; 116(1): 85 - 97.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. A. Towler
Imaging Aortic Matrix Metabolism: Mirabile Visu!
Circulation, January 23, 2007; 115(3): 297 - 299.
[Full Text] [PDF]


Home page
Circ. Res.Home page
R. C. Johnson, J. A. Leopold, and J. Loscalzo
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Circ. Res., November 10, 2006; 99(10): 1044 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-S. Shao, J. Cai, and D. A. Towler
Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1423 - 1430.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. L. Demer and Y. Tintut
Pitting Phosphate Transport Inhibitors Against Vascular Calcification
Circ. Res., April 14, 2006; 98(7): 857 - 859.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. A. Towler
Inorganic Pyrophosphate: A Paracrine Regulator of Vascular Calcification and Smooth Muscle Phenotype
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 651 - 654.
[Full Text] [PDF]